Two research papers describe how Google's Co-Scientist and nonprofit FutureHouse's AI tools can succeed at drug-retargeting tasks by forming hypotheses (John Timmer/Ars Technica)

May 20, 2026 - 11:45
Updated: 22 days ago
0 3
Diagram illustrating how artificial intelligence tools generate hypotheses for drug retargeting studies.

John Timmer / Ars Technica:
Two research papers describe how Google's Co-Scientist and nonprofit FutureHouse's AI tools can succeed at drug-retargeting tasks by forming hypotheses  —  Both tools generate hypotheses; one goes on to analyze some of the data.  —  On Tuesday, Nature released two papers describing AI systems intended …

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Wow Wow 0
Sad Sad 0
Angry Angry 0
Christopher Holloway

Christopher Holloway is the founder and director of Progressive Robot, a UK-based technology company. A full-stack engineer with more than two decades of experience, he works across PHP development, ecommerce, Linux infrastructure, technical SEO and AI automation, and writes here on technology, AI, hardware and software.

Comments (0)

User